{
    "paper_id": "8b78c1ebc0c43c7540b149814ee97aa2fb3e7d04",
    "metadata": {
        "title": "Authors: Ruchong Chen 1# , MD",
        "authors": [
            {
                "first": "Ruchong",
                "middle": [],
                "last": "Chen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ling",
                "middle": [],
                "last": "Sang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mei",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhaowei",
                "middle": [],
                "last": "Yang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Nan",
                "middle": [],
                "last": "Jia",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Wanyi",
                "middle": [],
                "last": "Fu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jiaxing",
                "middle": [],
                "last": "Xie",
                "suffix": "",
                "affiliation": {
                    "laboratory": "State Key Laboratory of Respiratory Disease",
                    "institution": "",
                    "location": {
                        "postCode": "22"
                    }
                },
                "email": ""
            },
            {
                "first": "Weijie",
                "middle": [],
                "last": "Guan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": ""
            },
            {
                "first": "Wenhua",
                "middle": [],
                "last": "Liang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhengyi",
                "middle": [],
                "last": "Ni",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yu",
                "middle": [],
                "last": "Hu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Huazhong University of Science and 29 Technology",
                    "location": {
                        "addrLine": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Lei",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hong",
                "middle": [],
                "last": "Shan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "The Fifth Affiliated Hospital of Sun Yat-sen University",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "32 China. 33 7. Guangzhou Eighth People's Hospital",
                        "postCode": "34",
                        "settlement": "Zhuhai, Guangdong, Guangzhou, Guangdong",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Chunliang",
                "middle": [],
                "last": "Lei",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yixiang",
                "middle": [],
                "last": "Peng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "The Central Hospital of Wuhan",
                    "location": {
                        "addrLine": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Li",
                "middle": [],
                "last": "Wei",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yong",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yahua",
                "middle": [],
                "last": "Hu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Peng",
                "middle": [],
                "last": "Peng",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jianming",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jiyang",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zhong",
                "middle": [],
                "last": "Chen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Gang",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zhijian",
                "middle": [],
                "last": "Zheng",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Shaoqin",
                "middle": [],
                "last": "Qiu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jie",
                "middle": [],
                "last": "Luo",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Changjiang",
                "middle": [],
                "last": "Ye",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Shaoyong",
                "middle": [],
                "last": "Zhu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jinping",
                "middle": [],
                "last": "Zheng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": ""
            },
            {
                "first": "Nuofu",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yimin",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": ""
            },
            {
                "first": "Jianxing",
                "middle": [],
                "last": "He",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jing",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {
                    "laboratory": "State Key Laboratory of Respiratory Disease",
                    "institution": "",
                    "location": {
                        "postCode": "22"
                    }
                },
                "email": "lijing@gird.cn"
            },
            {
                "first": "Shiyue",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": "lishiyue@188.com"
            },
            {
                "first": "Nanshan",
                "middle": [],
                "last": "Zhong",
                "suffix": "",
                "affiliation": {},
                "email": "nanshan@vip.163.com"
            },
            {
                "first": "Chen",
                "middle": [
                    "R"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Sang",
                "middle": [
                    "L"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jiang",
                "middle": [
                    "M"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yang",
                "middle": [
                    "Z"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jia",
                "middle": [
                    "N"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Fu",
                "middle": [
                    "W"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Xie",
                "middle": [
                    "J"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Guan",
                "middle": [
                    "W"
                ],
                "last": "Liang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "W",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ni",
                "middle": [
                    "Z"
                ],
                "last": "Hu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Y",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Liu",
                "middle": [
                    "L"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Shan",
                "middle": [
                    "H"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Lei",
                "middle": [
                    "C"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Peng",
                "middle": [
                    "Y"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Wei",
                "middle": [
                    "L"
                ],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hu",
                "middle": [
                    "Y"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Peng",
                "middle": [
                    "P"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Wang",
                "middle": [
                    "J"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Liu",
                "middle": [
                    "J"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Chen",
                "middle": [
                    "Z"
                ],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "G",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zheng",
                "middle": [
                    "Z"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Qiu",
                "middle": [
                    "S"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Luo",
                "middle": [
                    "J"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ye",
                "middle": [
                    "C"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zhu",
                "middle": [
                    "S"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zheng",
                "middle": [
                    "J"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zhang",
                "middle": [
                    "N"
                ],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "He",
                "middle": [
                    "J"
                ],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "J",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "S",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Zhong",
                "middle": [
                    "N"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Zhaowei",
                "suffix": "",
                "affiliation": {
                    "laboratory": "The Fifth Affiliated Hospital of Sun Yat-sen University",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "32 China. 33 7. Guangzhou Eighth People's Hospital",
                        "postCode": "34",
                        "settlement": "Zhuhai, Guangdong, Guangzhou, Guangdong",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Yang",
                "middle": [],
                "last": "1#",
                "suffix": "",
                "affiliation": {
                    "laboratory": "State Key Laboratory of Respiratory Disease",
                    "institution": "",
                    "location": {
                        "postCode": "22"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Nan",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jia",
                "middle": [],
                "last": "1#",
                "suffix": "",
                "affiliation": {
                    "laboratory": "State Key Laboratory of Respiratory Disease",
                    "institution": "",
                    "location": {
                        "postCode": "22"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Wanyi",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Fu",
                "middle": [],
                "last": "1#",
                "suffix": "",
                "affiliation": {
                    "laboratory": "State Key Laboratory of Respiratory Disease",
                    "institution": "",
                    "location": {
                        "postCode": "22"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [
                    "Lei"
                ],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Wei",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Yahua",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Hu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [
                    "Peng"
                ],
                "last": "Peng",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Zhong",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Chen",
                "middle": [],
                "last": "15",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [
                    "Gang"
                ],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "#ruchong",
                "middle": [],
                "last": "Chen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Clinical Research Center for Respiratory Disease, State Key Laboratory",
                    "institution": "Guangzhou Medical University",
                    "location": {
                        "addrLine": "27 3. Wuhan Jin-yin tan Hospital, Wuhan, Hubei",
                        "settlement": "Guangzhou",
                        "region": "Guangdong",
                        "country": "China, China"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Crucial roles of hematologic and immunologic responses in progression of COVID-19 74 remains largely unclear.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Objective: 76 We sought to address the dynamic changes of hematologic and immunologic 77 biomarkers and their associations with severity and outcomes of the disease. 78 Methods: 79 A retrospective study including 548 COVID-19 patients with clarified outcome 80 (discharged or deceased) from a national cohort in China was performed. 81 Cross-sectional and longitudinal variations were compared and the associations with 82 different severity and outcomes were analyzed.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "83 Results: 84 On admission, the counts of lymphocytes, T cell subsets, eosinophils and platelets 85 decreased markedly, especially in severe/critical and fatal patients. Increased 86 neutrophil count and neutrophils-to-lymphocytes ratio were predominant in 87 severe/critical cases or non-survivors. During hospitalization, eosinophils, 88 lymphocytes and platelets were shown an increasing trend in survivors, but 89 maintained lower levels or dropped significantly afterwards in non-survivors.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "90 Non-survivors kept high level or showed an upward trend for neutrophils, IL-6, 91 procalcitonin, D-dimer, amyloid A protein and C-reactive protein, which were kept 92 stable or shown downward trend in survivors. Positive correlation between CD8+ T 93 cell and lymphocytes count was found in survivors but not in non-survivors. A 94 multivariate Cox regression model suggested that restored levels of lymphocytes, 95 eosinophils and platelets could serve as the predictors for the recovery, while 96 progressive increases in neutrophils, basophils and IL-6 were associated with fatal 97 outcome. 98 Conclusions: 99 Hematologic and immunologic impairment showed a significantly different profile 100 between survivors and non-survivors in COVID-19 patients with different severity. 101 The longitudinal variations of these biomarkers could serve to predict recovery or 102 fatal outcome. 103 104 Abstract word count: 249 108 109 Clinical Implications: Restored lymphocytes, eosinophils and platelets could predict 110 recovery, while progressive increases in neutrophils and IL-6 were associated with 111 mortality. Altered interactions among immunologic and hematologic indices indicated 112 impaired immune responses in COVID-19.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "113 114 Capsule summary: Hematologic and immunologic impairments were found in 115 COVID-19 patients, which was significantly obvious in severe/critical and fatal cases 116 than in mild/moderate individuals and survivors. The longitudinal variations may 117 serve as the predictors for clinical outcome.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "118 Abbreviation List 119 ALI: acute lung injury 120 APPT: activated partial thromboplastin time 121 ARDS: acute respiratory distress syndrome 122 CI: confidence interval 123 COPD: chronic obstructive pulmonary disease 124 COVID-19: coronavirus disease 2019 125 CRP: C-reactive protein 126 EH: end-hospitalization 127 HR: Hazard ratio 128 IL-6: interleukin-6 129 IQR: interquartile range 130 MERS: middle east respiratory syndrome 131 MH: mid-hospitalization 132 NLR: neutrophils-to-lymphocytes ratio 133 OA: on admission 134 PCT: procalcitonin 135 PLR: platelets-to-lymphocytes ratio 136 PT: prothrombin time 137 SAA: amyloid A protein 138 SARS: severe acute respiratory syndrome 139 SARS-CoV-2: severe acute respiratory syndrome coronavirus 2 140 157 and the severity or mortality of the diseases. MERS-CoV infection induced T cells' 158 apoptosis by a combination of extrinsic and intrinsic apoptosis pathways, which might 159 contribute to virus spread and the severe immunopathologic dysregulations 14 . 160 However, little is known about how different lymphocytes subsets and the kinetic 161 changes in immuno-related biomarkers differ during difference prognosis and 162 outcomes of COVID-19. More importantly, whether these changes can help to predict 163 the outcome of the disease remain largely unclear.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "164",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "In this retrospective study, we aim to analyze clinical manifestations and outcomes, 165 hematologic, immunologic, lymphocytes subsets and infectious related bio-indices in 166 laboratory-confirmed cases based on a national cohort. With multivariate Cox 167 regression analysis, we attempt to investigate the potential risk factors associated with 168 the outcome of the disease.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "On December 31, 2019, a cluster of pneumonia cases of unknown origins in Wuhan 142 linked to exposure to seafood-market was reported 1 . The causative agent was 143 determined to be a novel \u03b2-coronavirus, which is currently named as severe acute ",
            "cite_spans": [
                {
                    "start": 79,
                    "end": 82,
                    "text": "142",
                    "ref_id": null
                },
                {
                    "start": 133,
                    "end": 134,
                    "text": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": "141"
        },
        {
            "text": "Continuous variables with normal distribution were described using mean \u00b1 standard 200 deviation (SD), otherwise, using median and interquartile range (IQR). Categorical 201 variables were described as number (percentage). We conducted t-test and 202 Mann-Whitney test to identify differences between survivors and non- ",
            "cite_spans": [
                {
                    "start": 247,
                    "end": 250,
                    "text": "202",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "199"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Clinical features of patients 585 infected with 2019 novel coronavirus in Wuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ren",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "A Novel Coronavirus 588 from Patients with Pneumonia in China",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "727--760",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "World Health Organization: Coronavirus disease 2019 (COVID-19) Situation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "1-sitrep-92-covid-19.pdf?sfvrsn=38e6b06d_4. Released by World Health 593 Organization on",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Characterization of",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Ultrapotent Human 598 Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Niu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Qin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Coronavirus From a Recovered Patient",
            "authors": [],
            "year": 2018,
            "venue": "J Infect Dis",
            "volume": "218",
            "issn": "",
            "pages": "1249--60",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Clinical Characteristics 601 of Coronavirus Disease 2019 in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "Y"
                    ],
                    "last": "Ni",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Q"
                    ],
                    "last": "Ou",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "X"
                    ],
                    "last": "He",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "60210.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Epidemiological and 604 clinical characteristics of 99 cases of",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Qu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Han",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "China: a descriptive study",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Wuhan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "507--520",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Characteristics of and Important Lessons From the",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Mcgoogan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "COVID-19) Outbreak in China: Summary of a Report 608 of 72314 Cases From the Chinese Center for Disease Control and Prevention",
            "authors": [],
            "year": 2019,
            "venue": "Coronavirus Disease",
            "volume": "609",
            "issn": "2020",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.2648"
                ]
            }
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Clinical course and risk factors 611 for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective 612 cohort study",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "1054--62",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Pathological findings of 614 COVID-19 associated with acute respiratory distress syndrome",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir 615 Med",
            "volume": "8",
            "issn": "",
            "pages": "420--422",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Haematological 617 manifestations in patients with severe acute respiratory syndrome: retrospective 618 analysis",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "F"
                    ],
                    "last": "To",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Lam",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "K"
                    ],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Leukoc Biol",
            "volume": "326",
            "issn": "",
            "pages": "1358--62",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Thrombocytopenia in patients with severe acute 701 respiratory syndrome (review)",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "K"
                    ],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Hematology",
            "volume": "10",
            "issn": "",
            "pages": "101--106",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Multicenter Retrospective Cohort Study",
            "authors": [],
            "year": 2017,
            "venue": "Crit Care Med",
            "volume": "45",
            "issn": "",
            "pages": "1683--95",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Thrombocytopenia is associated with severe 712 coronavirus disease 2019 (COVID-19) infections: A meta-analysis",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lippi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Plebani",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Henry",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Chim 713 Acta",
            "volume": "506",
            "issn": "",
            "pages": "145--153",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Predictors of MERS-CoV infection: A large case control study of patients 719 presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Ultrastructural Findings of a Fatal 723 Case of Middle East Respiratory Syndrome Coronavirus Infection in the United",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Clinicopathologic",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Longitudinal 726 characteristics of lymphocyte responses and cytokine profiles in the peripheral 727 blood of SARS-CoV-2 infected patients",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "Y"
                    ],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "B"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.02.16.20023671"
                ]
            }
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Human 740 immunopathogenesis of severe acute respiratory syndrome (SARS)",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Cameron",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Bermejo-Martin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Danesh",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Muller",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Kelvin",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Virus Res",
            "volume": "741",
            "issn": "",
            "pages": "13--22",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Aberrant pathogenic 743 GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe 744 pulmonary syndrome patients of a new coronavirus",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "G"
                    ],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "Q"
                    ],
                    "last": "Fu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "H"
                    ],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "J"
                    ],
                    "last": "Qi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "BioRxiv DOI",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.02.12.945576"
                ]
            }
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Effective Treatment of",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "L"
                    ],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "Q"
                    ],
                    "last": "Fu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Severe COVID-19 Patients with Tocilizumab",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Clinical 749 manifestations, laboratory findings, and treatment outcomes of SARS patients",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Sheng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "T"
                    ],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Yu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Hyperferritinemia and inflammation",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "F"
                    ],
                    "last": "Kernan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Carcillo",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Int Immunol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Structure and Expression of Different Serum Amyloid A (SAA) Variants and 755 their Concentration-Dependent Functions During Host Insults",
            "authors": [],
            "year": 2016,
            "venue": "Curr Med Chem",
            "volume": "756",
            "issn": "",
            "pages": "1725--55",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Protein chip array pneumonia",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Yip",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Yip",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "L"
                    ],
                    "last": "Kwan",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Clin Chem",
            "volume": "51",
            "issn": "",
            "pages": "47--55",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "18) 15 (8, 21) a' 17 (11, 24) \u2021 9",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Lopinavir-Ritonavir",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Adults Hospitalized with Severe Covid-19",
            "volume": "763",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2001282toadmission13"
                ]
            }
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "CD4/CD8",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "70.93) 0.67 68.43 (59.97, 72.61)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Data are presented as medians (IQR) and n/N (%). N is the total number of patients with available data",
            "authors": [],
            "year": null,
            "venue": "Abbreviations: IL",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "SAA, serum amyloid A protein; CRP, C-reactive protein",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "01 Survivors compared with Non-survivors; a p<0.05, a' p<0.01 compared with Mild/Moderate; b p<0.05, b' p<0.01 compared with Severe. # Lymphocytes subsets by flow cytometry were detected in a total of 141 subjects (19 with fatal outcome), with different severity (94 mild/moderate cases",
            "authors": [],
            "year": null,
            "venue": "PT, prothrombin time. \u2020 p<0.05, \u2021 p<0",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "144 respiratory syndrome coronavirus 2 (SARS-CoV-2) 2 . The disease has been named as 145 the Coronavirus Disease-2019 (COVID-19) by the World Health Organization.. Until 146 April 21, 2020, the outbreak of COVID-19 was reported in more than 2.3 million 147 confirmed cases globally 3 . Despite a reportedly lower fatality rate compared with the 148 10% of severe acute respiratory syndrome (SARS) 4 and 37% of middle east 149 respiratory syndrome (MERS) 5 , COVID-19 has killed 4642 people in China and 150 158314 people outside China (by April 21, 2020) 3 . 151 Studies have revealed some changes in hematologic and immunologic indices in 152 patients with COVID-19 6-8 . The acute phase of the disease was found to be marked 153 lymphopenia, involving a dramatic loss of CD4+ T and CD8+ T cells 9,10 . Several 154 studies on SARS-CoV 11 , MERS-CoV 12 or SARS-CoV-2 13 infections have 155 investigated the correlation between abnormalities on laboratory indices including 156 leukocytes, lymphocytes and eosinophils counts, serum inflammatory cytokine levels Methods 170 Led by the China national health commission, a retrospective cohort to study the 171 laboratory confirmed COVID-19 admitted cases from 575 hospitals throughout China 172 was established 6 . The diagnosis of COVID-19 was made based on the World Health 173 Organization interim guidance 15 . By the time of March 22 nd , 2020, a total of 548 cases 174 with the clarified outcome (discharged or deceased) from the cohort were included, 175 patients with incomplete medical records or still in the hospitals were excluded. The 176 severity of the disease was assessed according to the Seventh Version of the Novel 177 Coronavirus Pneumonia Diagnosis and Treatment Guidance from national health 178 commission of China 16 . According to the severity, patients were categorized into 179 mild/moderate, severe or critical group upon admission. The study was approved by 180 national health commission and the ethics commission of the First Affiliated Hospital 181 of Guangzhou Medical University. The requirement for informed consent was waived 182 by the ethics commission due to the emerging infectious disease, records were copied and sent to the data processing center in Guangzhou, 187 under the coordination of the national health commission. A team of experienced 188 respiratory clinicians reviewed and abstracted the data. Data were entered into a 189 computerized database and cross-checked. The clinical data (including demographic 190 data, clinical symptoms and signs, comorbidities, laboratory findings, treatments 191 during hospitalization and clinical outcome) were extracted from electronic medical 192 records. Laboratory assessments consisted of complete blood counts, T cell subsets, 193 inflammatory indices, coagulation function, etc. The differences of the clinical 194 characteristics and laboratory findings in patients with different outcome or severity 195 would be addressed. Longitudinal tracing of the laboratory indices during the 196 hospitalization were performed. Furthermore, independent predicting factors 197 associated with the fatal outcome would also be investigated.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "We selected correlation strength by an absolute correlation |r|>0.2. The selected 210 connections were plotted as an undirected network graph with the width of the edge 211 proportional to correlation strength. A principal component analysis (PCA) of 212 variables on admission or at end-hospitalization was conducted using R package 213 FactoMineR (v1.42). Biplot was used to signify the proportions of the individual 214 variable on principal components. 215 Differences in indexes between end-hospitalization and on admission were calculated 216 and presented as \u2206 (\u2206index(a) = index(a) at end-hospitalization minus index(a) on 217 admission",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "260tendency of CD8+ T cell counts was detected in non-survivors (p=0.077). In the 261 comparison among patients with different severity, a significant decrease in total 262 counts of CD3+ T, CD4+ T and CD8+ T cells was found in more severe patients. The263 percentage of CD8+ T cells in severe/critical patients was significantly lower 264 compared with mild/moderate patients (p<0.01). 265 Compared with survivors, non-survivors showed significantly increased levels of 266 interleukin-6 (IL-6), C-reactive protein (CRP), procalcitonin (PCT), amyloid A 267 protein (SAA), ferritin and D-dimer (all p<0.01). CRP, PCT and ferritin also showed 268 a significant increasing trend with severer condition of the disease. Regarding to the 269 coagulation indicators, the indexes of D-dimer and prothrombin time (PT) increased 270 significantly in non-survivors, or the patients with severer condition.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "illustrated schematic diagram of dynamic changes of hematologic and 274 inflammatory biomarkers in survivors and non-survivors during progression of 275 COVID-19 across on admission, mid-hospitalization and end-hospitalization. 276 To further understand their dynamic changes, we classified those biomarkers into 277 three distinct patterns. Three hematologic cells in pattern 1, including eosinophils, 278 lymphocytes and platelets, showed a significant continuous upward trend in survivors, 279 but a downward trend or keeping low in non-survivors (Figure 1A-C). On admission, 280 regardless of the severity or the outcome, majority of patients present an identical 281 eosinopenia. Level of lymphocytes was inversely proportional to disease severity, 282 with the highest in mild survivors and the lowest in critical survivors. During 283 hospitalization, survivors showed an increasing trend for both eosinophils (6-fold in 284 mid-term, and 8-fold at the end of hospitalization, p<0.001) and lymphocytes (1.2 -fold in mid-term, and 1.4-fold at the end of hospitalization, p<0.001), however, 286 non-survivors remained at low-level without a noteworthy increase. For platelets, 287 survivors showed a significantly higher level on admission and an increasing trend 288 during hospitalization (1.25-fold in mid-term and 1.24-fold at the end of 289 hospitalization, p<0.001) whereas non-survivors started with a low-level and dropped 290 significantly afterwards(1.07-fold and 2.13-fold, p<0.001). 291 Biomarkers in pattern 2 including leukocytes, neutrophils, NLR, IL-6, PCT, d-dimer, 292 PT, SAA, CRP and ferritin, were maintained at significant lower levels or showed a 293 slightly downward trend in survivors. In contrast, those biomarkers showed an 294 upward trend or maintained at higher levels in non-survivors (Figure 1D-N). Take an 295 example of IL-6, in severe or critical patients, significantly higher levels were found 296 in non-survivors (severe: 9.7 pg/mL, critical: 10.5 pg/mL) than in survivors (severe: 297 7.2 pg/mL, critical: 6.2 pg/mL) on admission (p<0.001). During hospitalization, 298 survivors had comparable levels of IL-6 across three time points. Whereas, at 299 end-hospitalization, a 1.2-, 1.5-and 2.2-fold increase compared with on admission 300were found in mild/moderate, severe or critical cases with fatal outcome, respectively 301 (Figure 1L). Furthermore, there is no clear pattern of basophils and PLR(Figure 1",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "and principal component analysis for immunologic cells 305 and biomarkers 306 On admission(Figure 2), both non-survivors and survivors showed strong positive 307 correlation between CD4+ T cell and CD8+ T cell count (r=0.69 and r=0.71, 308 respectively), and CD4+ T vs. lymphocyte count (r=0.62 and r=0.72, respectively).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Similar positive correlations were observed between CD4+ T cell count and CD4+ T 310 cell% (r=0.65 and r=0.61), CD8+ T cells count and CD8+ T cell% in all patients 311 (r=0.58 and r=0.57). We observed a positive correlation between CD8+ T cells and 312 lymphocyte count in survivors (r=0.69), but not in non-survivors. In contrast, 313 non-survivors showed a negative correlation between lymphocytes count and CD8+ T cell % (r=-0.56). CD8+ T cell% and CD8+ cells count were two highly connected 315 hub nodes in the non-survivor biomarker network (6 edges, Figure 2A). 316 When at end-hospitalization, strong correlations between basophil and neutrophil 317 (r=0.53), and basophil and lymphocyte counts (r=0.47) were observed in 318 non-survivors but not in survivors. Furthermore, non-survivors showed stronger 319 negative correlations between PCT and eosinophil (r=-0.42 in non-survivors and 320 r=-0.23 in survivors), PCT vs. platelets (r=-0.37), and CRP and platelets (r=0.33) than 321 survivors. Collectively, strong correlations between immunologic cells and infection 322 biomarkers were still found in non-survivors, but not in survivors. 323 A biplot via principal component analysis showed the configuration of biomarkers on 324 admission and at end-hospitalization, which is shown at Figure 3. On admission, the 325 first principal component (PC1) separated non-survivors from survivors. Twelve 326 biomarkers significantly associated positively or negatively with PC1, with 327 lymphocytes (20.1%), CD4+ T cell (13.9%) and CD8+ T cell (7.9%) having the 328 biggest positive contribution. Notably, the spectrum of lymphocytes and their subsets 329 in the principal component analysis is consistent with what is shown in the biomarker 330 correlation networks (Figure 2). At end-hospitalization, non-survivors and survivors 331 showed more marked separation along PC1. Platelets (12.6%), lymphocytes (3.4%) 332 and eosinophils (2.3%) were positively associated with PC1, whereas CRP (25.1%), 333 ferritin (16.4%) and SAA (14.3%) showed negative contribution on PC1.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "for the fatal outcome 336 The Kaplan-Meier and log-rank test showed the significant difference of survival 337 curve in patients with COVID-19 categorized by the level of eosinophils, platelets on 338 admission, the level of changes in neutrophils, lymphocytes, eosinophils, platelets, 339 basophils, IL-6 from on admission to end-hospitalization, respectively (Figure 4).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": ", based on the multivariate Cox regression model, we found age>60 (HR: 2.49, 341 95%CI: 1.08-5.72), \u2206Neutrophils>0.5\u00d710 9 /L (HR: 4.17, 95%CI: 1.83-9.51), study, longitudinal variations of hematologic and immunologic 351 biomarkers associated with the severity and progression of COVID-19 were 352 investigated. Some novel findings were found as below. Firstly, not only the 353 lymphocytes and their subsets, but also the eosinophils decreased at the early stage, 354 associating with disease severity and clinical outcome. Altered immunologic 355 interactions among T cell subsets and hematologic indices in non-survivors indicated 356 impaired immune responses in COVID-19. Secondly, during the hospitalization, 357 dynamic changes of hematologic and immunologic indices varied in survivors and 358 non-survivors. Finally, multivariate Cox regression model suggested that restored 359 levels of lymphocytes, eosinophils and platelets could serve as the predictors of 360 recovery, while progressive increases in neutrophils, basophils and IL-6 were risk 361 factors for fatal outcomes of COVID-19. 362 Coronavirus infection (SARS and MERS) are confirmed to activate both innate 363 and adaptive immune responses. With the progression of the disease, uncontrolled 364 inflammatory responses may lead to subsequently local and systematic tissue injury. A 365 marked decrease in lymphocyte count has been reported associated with disease 366 severity of SARS and COVID-19 17-19 . We confirmed observations of a significantly 367 lower lymphocyte count and higher lymphopenia percentage on admission in 368 severe/critical COVID-19 patients than in mild/moderate ones. Furthermore, we 369 extend the observation by comparing lymphocyte levels between survivors and 370 non-survivors, showing that the initial levels of absolute lymphocyte count were 371 significantly lower and lymphopenia percentage significantly higher in non-survivors, regardless of the initial disease severity. Our data also revealed that the decreased 373 lymphocyte count was recovered to the normal level in survivors, while it was 374 sustained at low level in non-survivors, suggesting that restored lymphocyte numbers 375 are associated with the curative outcome of COVID-19.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "We further analyzed T lymphocyte subsets and confirmed the observation of 377 significant reduction of CD3+, CD4+ and CD8+ T cell subsets in severe/critical 378 patients than in mild/moderate ones 10, 20, 21 . Unfortunately, we couldn't obtain the379 kinetic changes of T cell subsets, since only samples on admission were performed 380 with flow cytometry in our patients. However, given the notification of marked 381 decreased initial counts of CD3+, CD4+ and CD8+ T cell subsets in non-survivors 382 than in survivors, we could speculate marked impairment of T lymphocytes is 383 associated with fatal outcome in COVID-19 patients. Decline of T lymphocytes via T 384 cell apoptosis in SARS and MERS patients is implicated to diminish the T cell 385 response, leading to further exuberant inflammatory responses 22,23 . Recent report by 386 Wang's group proved that SARS-CoV-2 could directly infect T cells through 387 receptor-dependent spike protein-mediated membrane fusion, despite a very low 388 expression level of angiotensin-converting enzyme 2 (ACE2) receptor in T cells 24 . 389 Further researches are needed to investigate whether SARS-CoV-2 infection could 390 induce T cells apoptosis. 391 In case of SARS, the CD4+/CD8+ ratio did not change significantly among 392 diverse severity or at different time points 11,25 . From current research, CD4+/CD8+ 393 ratio was found with no obvious difference among different severity, but with a 394 significant increase in non-survivors than in survivors. These findings indicate that 395 greater loss of CD8+ T cells might lead to fatal outcome in COVID-19 patients.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "CoV-specific T cells, especially CD4+ and CD8+ T cells, are crucial for virus 397 clearance and limiting further damage to host. Compared to CD4+ T cells which398 largely function via indirect mechanisms, virus specific CD8+ T cells directly target 399 infected cells 26 . Greater loss of CD8+ T cells might correlate to impaired virus 400 elimination in the early stage. Intriguingly, we found different correlations between CD8+ T cells and lymphocytes in non-survivors from survivors, indicating other 402 mechanisms underlying CD8+ T cells exhaustion might be involved. A pilot study 403 including 13 severe cases showed that the CD8+ T cells were functionally exhausted 404 in patients with COVID-19 through upregulation of an immune-checkpoint inhibitory 405 receptor, NKG2A. NKG2A + CD8+ T cells were found with increased percentage and 406 displayed a reduced ability to produce CD107a, IFN-\u03b3, IL-2 and granzyme B. The 407 upregulated expression of NKG2A normalized in recovery subjects 27 . Aside from 408 reduction of cell numbers, functional exhaustion of CD8+ cells might contribute to 409 disease progression of COVID-19.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "In our study, most of the severe/critical and fatal patients demonstrated 411 eosinopenia, showing much lower level than mild/moderate and survival subjects on 412 admission. This result was consistent with those of other studies with acute infections 413 caused by SARS-CoV 28 MERS-CoV 12 and SARS-CoV-2 29,30 . The decline in 414 eosinophils might be owing to the response to stress of acute SARS-CoV-2 infection 31 . 415 Patients with severe respiratory syncytial virus infection had significantly higher 416 plasma cortisol levels and significantly lower eosinophil counts 32 . Other studies also 417 reported significantly decreased eosinophils in subjects with stress of heat 33 and force 418 swim 34 . However, whether SARS-CoV-2 has a direct effect on eosinophils remain 419 unknown. Recently, study found that the toxin of C. difficile transferase induces 420 pathogenic host inflammation via a Toll-like receptor 2 (TLR2)-dependent pathway, 421 resulting in the suppression of a protective host eosinophilic response 35 . In 422 experimental human endotoxemia, circulatory eosinopenia after an innate immune 423 challenge (intravenous challenge with endotoxin) is mediated by CD49d-mediated 424 homing of eosinophils to the tissues 36 . Similarly, with Liu's report 29 , we found 425 eosinophils continually increased and reached significantly higher levels in survivors 426 as compared with non-survivors, and a greater increase in eosinophils was associated 427 with better outcome in our Cox regression model. All the above findings suggest that 428 eosinophils might contribute to antiviral immunity in the lungs, and levels of 429 eosinophil counts at early stage and the kinetic changes may predict COVID-19 progression and recovery. 431 Our study indicated the platelets count as a clinical indicator of disease severity 432 and risk of mortality during hospitalization. Thrombocytopenia was identified as a 433 significant risk factor for disease severity and mortality in both SARS-CoV 37,38 and 434 MERS-CoV infected patients 39 . Furthermore, platelet count was selected in two 435 prognosis regression models by multivariate analysis 38,40 . A recent meta-analysis with 436 1779 COVID-19 patients revealed that the platelet count was significantly lower in 437 severe patients and even lower in non-survivors 41 . A hypothesis suggested that 438 damage to the lung tissue and pulmonary endothelial cells by virus infection would 439 result in 1) platelet activation, aggregation and entrapment, and further increasing the 440 consumption of platelets/megakaryocytes, and 2) reducing the production of platelets 441 in the lungs 37 . 442 Neutrophil dysfunction was previously reported as a distinct inflammatory 443 signature involved in the pathogenesis of SARS and MERS 22 . Severe outcomes, 444 including acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and 445 death, are associated with massive neutrophil infiltration in the lung and dramatically 446 elevated neutrophil counts in the peripheral blood 11, 42-44 . Higher neutrophil count on 447 admission was found in severe or critical than mild/moderate patients in our cohort, 448 consistent with previous reports 1,45 . Notably, kinetic analysis further revealed a 449 significant increase in initial neutrophil count, which persisted at higher levels at 450 end-hospitalization, was correlated with the fatal outcome. The NLR has been 451 reported as an independent predictor of disease severity in COVID-19 patients 45,46 .452We confirmed observation of higher initial NLR in severe/critical patients, and further 453 evaluated the potential of NLR as a prognostic factor. Compared to those in survivors 454 with low initial and a progressive declined NLR, significant higher NLR sustained 455 from on admission to end-hospitalization in non-survivors. Our results indicate that 456 NLR may serve as a potential factor for early identification of severity and to further 457 predicate outcomes in COVID-19.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": ", then the virus activates innate immune system and adaptive immune462    system, resulting in the release of a large number of cytokines, including IL-6.463    Abnormality high levels of these cytokines/chemokine are considered to lead to tissue464 damage, accounting for respiratory failure or multiple organ failure. Among various 465 cytokines and chemokines (IL-2, IL-8, IL-17, GCSF, IP-10 and TNF\u03b1) identified, 466 IL-6 is one of the key cytokines with increased plasma level in both SARS and MERS, 467 as well as in COVID-19 21,47-49 . In accord with previous studies 20,21 , IL-6 was found 468 with a higher level on admission in non-survivors, as well as a marked increase 469 especially at the end of hospitalization compared to those in survivors. This indicates 470 that a sustained high level of IL-6 is related to a fatal outcome of SARS-CoV-2 471 infection. Interfering IL-6 by tocilizumab has been reported effectively improved 472 clinical symptoms and repressing the deterioration of severe and critical patients 50,51 .473Although not sufficient, our findings provide the further evidence that, in addition to 474 antiviral treatment of directly targeting or blocking viral entry, IL-6 may serve as a 475 potential therapeutic target for severe/critical COVID-19 patients.476Other conventional makers related to inflammatory damage, such as CRP, were 477 also significantly elevated in non-survivors at early stage and showed an upward trend 478 with progression, which is similar as reported in SARS 52 . Ferritin and SAA also 479 belong to acute phase proteins and can be used as prognostic markers for tissue injury480 or acute infections 53,54 . SAA was demonstrated a positive correlation with the extent 481 of pneumonia in SARS 55 . In the current study, consistent high levels of serum ferritin 482 and SAA were present in non-survivor during the hospitalization. Our study, with 483 another study on COVID-19 9 , found out a dynamic increasing of ferritin in 484 non-survivors since on admission. The longitudinal observation on these indexes 485 indicated the progressive immune-mediated damage in deceased patients. 486 From biomarker correlation networks, we found a significant 487 interaction among hematologic and immunologic cells in both survivors and non-survivors on admission, but with different patterns. It might indicate immunology 489 profile associated with host antiviral defense varied in different status. However, 490 comparing with subsiding of cell-to-cell interactions in survivors, strong correlations 491 sustained till end-hospitalization in non-survivors, suggested higher virus load plus 492 inflammatory turbulence might contributed to mortality of COVID-19. Currently, Cao 493 et al. reported that no benefit was observed with lopinavir-ritonavir treatment beyond 494 standard care in severe patients with COVID-19 56 . It is reasonable that combining 495 usage of anti-inflammatory and anti-viral medications may be more effective than 496 using either alone. Beside the tocilizumab, novel immune-mediated strategies (e.g. 497 mesenchymal stem cells), are under the trial to dampen inflammatory responses and 498 attenuate the inflammatory injury in COVID-19.499 Our study has several limitations. Firstly, due to the design of a retrospective study, 500 some indices were not detected in all patients. Lacking in the follow-up data of the T 501 cell subsets failed to perform a longitudinal analysis to unreal the recovery trends. 502 Secondly, except for the serum IL-6 and some clinical infection indexes, other 503 pro-inflammatory cytokines or chemokines associated with lymphocytes were not 504 detected. Further studies are necessary to characterize the role of T cell immune 505 response in COVID-19. Thirdly, data on the virus shedding or viremia profile are not 506 available, studies are further needed to describe the association between the virus 507 loading kinetics and the dynamic immune responses. study demonstrates hematologic and immunologic variations associated with 511 the severity and progression of COVID-19. Since the early stage of the disease, not 512 only the lymphocytes and T cell subsets, but also eosinophils present a marked 513 decrease, associating with the disease severity and clinical outcome. Altered 514 immunologic interactions among T cell subsets and hematologic indices suggests the 515 impaired immune response since the onset of the disease. Dynamic changes of 516 hematologic and immunologic indices varied in survivors and non-survivors, and could serve as the predictors of recovery or fatal outcome of COVID-19.518 519 Author's contributions: J.L, S.Y.L and N.S.Z had full access to all the data in the 520 study and takes responsibility for the integrity of the data and the accuracy of the data 521 analysis. R.C.C, L.S, M.J, Z.W.Y, N.J, W.Y.F, J.L, S.Y.L and N.S.Z participated in 522 study conception. J.X.X, W.J.G, W.H.L, Z.Y.N, Y.H, L.L, H.S, C.L.L, Y.X.P, L.W, Y.L, 523 Y.H.H, P.P, J.M.W, J.Y.L, Z.C, G.L, Z.J.Z, S.Q.Q, J.L, C.J.Y, S.Y.Z, J.P.Z, N.F.Z, 524 Y.M.L and J.X.H recruited patients and collected data. R.C.C, M.J, Z.W.Y, J.L 525 performed data analysis. R.C.C, L.S, M.J, Z.W.Y, N.J, W.Y.F, J.L, S.Y.L and N.S.Z 526 drafted and revised the paper. All authors approved the final draft of the manuscript 527 for publication.528 529 Additional Contributions: We sincerely thank all the healthcare providers fighting 530 against this public crisis and all the patients involved in the study. We thank the 531 hospital staff for their efforts in collecting the information. We are indebted to the 532 coordination of Drs. Zong-jiuZhang, Ya-hui Jiao, Bin Du, Xin-qiang Gao and Tao Wei 533 (National Health Commission), Yu-fei Duan and Zhi-ling Zhao (Health Commission 534 of Guangdong Province), Zi-jing Liang, Qing-hui Huang, Wen-xi Huang and Ming Li 535 (Guangzhou Institute of Respiratory Health) which greatly facilitate the collection of 536 patient's data. We thank Wei Xu (Department of Biostatistics, Princess Margaret 537 Cancer Centre, Toronto, Ontario, Canada) for his suggestion on the statistical analysis.538 We also thank Li-qiang Wang, Wei-peng Cai, Zi-sheng Chen (the sixth affiliated 539 hospital of Guangzhou medical university), Mu-lin Feng, Run-dong Qin, Ren-bin 540 Huang, Si-yang Yao, Jing-wei Liu, Xin-liu Lin, Tian Luo, Li He, Yu-kai Liu, Chen 541 Zhan, Li-man Fang, Shu-xin Zhong, Chang-xing Ou, Xiao-min Peng, Si-ni Cui, Yuan 542 Wang, Mou Zeng, Xin Hao, Qi-hua He, Jing-pei Li, Xu-kai Li, Wei Wang, Li-min Ou, 543 Ya-lei Zhang, Jing-wei Liu, Xin-guo Xiong, Wei-juna Shi, San-mei Yu, Run-dong Qin, 544 Si-yang Yao, Bo-meng Zhang, Xiao-hong Xie, Zhan-hong Xie, Wan-di Wang, Li-fen Gao, Jia-bo Gao, Cai-chen Li, Xue-wei Chen, Jia-bo Gao, Ming-shan Xue, 548 Shou-xie Huang, Jia-man Tang, Wei-li Gu, Jin-lin Wang (Guangzhou Institute of 549 Respiratory Health) for their dedication to data entry and verification. We express 550 sincere sympathies and deep condolences to the victims and bereaved families. Dynamic changes of hematologic and immunologic biomarkers in 554 COVID-19 patients across three time periods, including on admission (OA), 555 mid-hospitalization (MH) and end-hospitalization (EH). Medium value of three 556 time periods was showed in patients with mild, severe or critical severity on 557 admission for both survivors and non-survivors. The significant difference between 558 survivors and non-survivors in each of three severity groups was compared using 559 Kruskal-Wallis test and indicated as \u2020 (p \u2264 0.05) and \u2021 (p \u2264 0.01). SAA, Serum 560 amyloid protein A; CRP, high-sensitivity C-reactive protein. Correlation networks for immunologic cells and biomarkers. Networks 562 showed different profiles of correlations in COVID-19 non-survivors (A/C) and 563 survivors (B/D), on admission (A/B) and end-hospitalization (C/D). The width of the 564 edge showing stronger or weaker interactions is proportional to the absolute value of 565 biomarker-biomarker correlation (|r|). Edges were showed only when |r| > 0.2. A 566 purple edge indicates a positive correlation and a blue edge indicates a negative 567 correlation. SAA, Serum amyloid protein A; CRP, high-sensitivity C-reactive protein; PCA biplot of biomarkers on admission (A) or at end-hospitalization 570 (B). Samples are shown as dots and colored by outcomes (survivors and 571 non-survivors). Biomarkers shown as lines with arrows. The configuration of 572 biomarkers on biplot represented relationship between variables and principal 573 components. Kaplan-Meier survival plots for different prognostic factors. 575 Kaplan-Meier survival plots according to (A)Eosinophil OA, (B) Platelets OA, (C) \u2206 576 Neutrophils, (D) \u2206 Lymphocytes, (E) \u2206 eosinophils, (F) \u2206 Basophils, (G) \u2206 Platelets 577 and (H) \u2206 IL-6. \u2206 index(a)= index(a) end-hospitalization-index(a) on admission. OA, 578 on admission.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "Risk factors of fatal outcome in the Multivariate Cox proportional 580 hazards regression model. Shown in the figure are the hazards ratio (HR) and the 95% 581 confidence interval (95%CI) associated with the endpoint. \u2206 index(www.who.int/publications-detail/clinical-management-of-severe-acute-res 630 piratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. //www.who.int/docs/default-source/wpro---documents/countries/china/covi 635 d-19-briefing-nhc/1-clinical-protocols-for-the-diagnosis-and-treatment-of-covid-636 19-v7.pdf?sfvrsn=c6cbfba4_2. Released by National Health Commission & State 637 Administration of Traditional Chinese Medicine on March 3, 2020.638 17. Cui W, Fan Y, Wu W, Zhang F, Wang JY, Ni AP. Expression of lymphocytes 639 and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin 640 Infect Dis 2003; 37:857-9.641 18. Pedersen SF, Ho YC. SARS-CoV-2: A Storm is Raging. J Clin Invest 2020. DOI: 642 10.1172/JCI137647. 643 19. Li T, Qiu Z, Han Y, Wang Z, Fan H, Lu W, et al. Rapid loss of both CD4+ and 644 CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory 645 syndrome. Chin Med J (Engl) 2003; 116:985-7. 646 20. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune 647 response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020. 648 DOI: 10.1093/cid/ciaa248. 649 21. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and 650 immunologic features in severe and moderate Coronavirus Disease 2019. J Clin 651 Invest 2020. DOI: 10.1172/JCI137244. 652 22. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes 653 and consequences of cytokine storm and immunopathology. Semin 654 Immunopathol 2017; 39:529-39.655 23. Chu H, Zhou J, Wong BH, Li C, Chan JF, Cheng ZS, et al. Middle East 656 Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T 657 Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways. J 658 Infect Dis 2016; 213:904-14. 659 24. Wang X, Xu W, Hu G, Xia S, Sun Z, Liu Z, et al. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of 669 antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 2020.670 28. Lee YS, Chen CH, Chao A, Chen ES, Wei ML, Chen LK, et al. Molecular 671 signature of clinical severity in recovering patients with severe acute respiratory 672 syndrome coronavirus (SARS-CoV). BMC Genomics 2005; 6:132. 673 29. Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, et al. Patients of COVID-19 may 674 benefit from sustained lopinavir-combined regimen and the increase of 675 eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis 676 2020.DOI: 10.1016/j.ijid.2020.03.013. 677 30. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical 678 characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. 679 Allergy 2020.DOI: 10.1111/all.14238. 680 31. He L, Ding Y, Zhang Q, Che X, He Y, Shen H, et al. Expression of elevated 681 levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in 682 SARS patients: relation to the acute lung injury and pathogenesis of SARS. J 683 Pathol 2006; 210:288-97. 684 32. Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Diaz PV. T helper 1/T helper 685 2 cytokine imbalance in respiratory syncytial virus infection is associated with 686 increased endogenous plasma cortisol. Pediatrics 2006; 117:e878-86. 687 33. Ju XH, Xu HJ, Yong YH, An LL, Jiao PR, Liao M. Heat stress upregulation of 688 Toll-like receptors 2/4 and acute inflammatory cytokines in peripheral blood 689 mononuclear cell (PBMC) of Bama miniature pigs: an in vivo and in vitro study.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "20.2% variance explained) PC2 (12.7% variance explained) 27.3% variance explained) PC2 (15.1% variance explained)",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "survivors for continuous variables. ANOVA or Kruskal-Wallis test was performed to compare the difference among three groups of patients with different severity , then Tukey or Dunn's test was used for multiple comparisons as appropriate. Chi-square test and Fisher's exact test were applied to categorical variables with false discovery rate correction for multiple comparisons. We calculated the pairwise Spearman correlations (r) between indexes for different time or survivor/non-survivor outcome.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "). Survival curves were depicted using the Kaplan-Meier method and compared using the log-rank test. The prognostic effect of each variable including \u2206index was clarified by Cox proportional hazards regression model. A final model selection was performed by a backward selection of all factors with the Akaike information criterion. Estimates of adjusted hazard ratios (HRs), 95% confidence interval (CI), and p value are displayed. Analyses were conducted using R software Version 3.6.1 (http://CRAN.R-project.org, R Foundation, Vienna, Austria). All p values were based on two-sided tests and were considered statistically significant at Demographics and baseline clinical characteristics229    A total of 548 patients with laboratory confirmed diagnosis of COVID-19 were included, with 345 patients categorized into mild/moderate, 155 severe and 48 critical degree on admission. The fatality rate was 60% in critical cases, followed by 34% in severe and 6% in mild/moderate patients (p<0.001). The mean age for all patients was 56 years with significantly older age for non-survivors than survivors (66.9 vs. 53.5, p<0.001). Among all non-survivors, 67% was male, reaching 83% in critical patients.Symptoms of cough, sputum and dyspnea were found significantly more common in severe or critical patients compared with mild/moderate counterparts (all p<0.05), and in non-survivors as compared with survivors (all p<0.05). Two hundred and forty-one 238 (44%) patients had at least one underlying comorbidity, of which 27% with hypertension, 11% with diabetes, 3% with cerebrovascular disease, which was significantly higher in non-survivors than survivors (all p<0.001). Only 2 (0.4%) patients reported having asthma and 18 (3%) reported other allergic diseases mostlyInitial laboratory findings among hospitalized patients with different outcomeOn admission, the hematologic profile varied among patients with different outcome and severity(Table 2). Compared with the survivors, eosinopenia, lymphopenia, and decreased platelets were much common in non-survivors (all p<0.05), which accounted for 80.5%, 96.6% and 34.5%, respectively. The trend of the gradual decreasing of eosinophils and lymphocytes among patients with varying degree of severity was identical. Oppositely, non-survivors showed significantly elevated level of leukocytes, neutrophils, the neutrophils-to-lymphocytes ratio (NLR) and the platelets-to-lymphocytes ratio (PLR) (all p<0.05). Moreover, compared with mild/moderate, severe and critical patients showed a higher incidence of abnormal leukocytes, neutrophils, NLR and PLR.T cell subsets were further analyzed in 141 patients on admission (demography showed in supplementalTable E1). In patients with different outcomes, non-survivors showed significant decrease in total number of CD3+ T cells, CD4+ T and CD8+ T cells in peripheral blood, compared with survivors (all p<0.001). A decreased",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "al. Stress amplifies lung tissue mechanics, inflammation and oxidative stress induced by chronic inflammation. Exp Lung Res 2012; 38:344-54. 35. Cowardin CA, Buonomo EL, Saleh MM, Wilson MG, Burgess SL, Kuehne SA, et al. The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia. Nat Microbiol 2016; 1:16108. 36. Hassani M, Leijte G, Bruse N, Kox M, Pickkers P, Vrisekoop N, et al. 47. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot-Pocidalo MA. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996; 154:594-601. 48. Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et al.",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Demographics and baseline characteristics of COVID-19 patients with different severity and outcome.Data are presented as mean \u00b1 standard deviation (SD), medians (IQR) and n/N (%). Abbreviations: COPD: Chronic obstructive pulmonary disease. \u2020 p<0.05, \u2021 p<0.01 Survivors compared with Non-survivors; a p<0.05, a' p<0.01 compared with Mild/Moderate; b p<0.05, b' p<0.01 compared with Severe.",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Initial laboratory findings among hospitalized patients with different outcome and severity.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "P mg/L mg/L ng/mL mg/L pg/mL ng/mL ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}